This is great news for anyone with AFIB...Warfarin / Coumadin replacement
FDA NEWS RELEASE
For Immediate Release: Oct. 19, 2010
Media Inquiries: Sandy Walsh, 301-796-4669; sandy.walsh@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
FDA approves Pradaxa to prevent stroke in people with atrial fibrillation
The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).
“Unlike warfarin, which requires patients to undergo periodic monitoring with blood tests, such monitoring is not necessary for Pradaxa,†Stockbridge says.
In the trial, patients taking Pradaxa had fewer strokes than those who took warfarin.